These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24771266)

  • 1. Down-regulation of EphB4 phosphorylation is necessary for esophageal squamous cell carcinoma tumorigenecity.
    Hu F; Tao Z; Shen Z; Wang X; Hua F
    Tumour Biol; 2014 Jul; 35(7):7225-32. PubMed ID: 24771266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
    Tachibana M; Tonomoto Y; Hyakudomi R; Hyakudomi M; Hattori S; Ueda S; Kinugasa S; Yoshimura H
    Dig Liver Dis; 2007 Aug; 39(8):725-32. PubMed ID: 17611172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of VGLL4 in the progression of esophageal squamous cell carcinoma.
    Jiang W; Yao F; He J; Lv B; Fang W; Zhu W; He G; Chen J; He J
    Tumour Biol; 2015 Feb; 36(2):1289-97. PubMed ID: 25352025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
    Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
    Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-675-5p enhances tumorigenesis and metastasis of esophageal squamous cell carcinoma by targeting REPS2.
    Zhou YW; Zhang H; Duan CJ; Gao Y; Cheng YD; He D; Li R; Zhang CF
    Oncotarget; 2016 May; 7(21):30730-47. PubMed ID: 27120794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein arginine methyltransferase 1 promoted the growth and migration of cancer cells in esophageal squamous cell carcinoma.
    Zhou W; Yue H; Li C; Chen H; Yuan Y
    Tumour Biol; 2016 Feb; 37(2):2613-9. PubMed ID: 26392112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RACK1 promoted the growth and migration of the cancer cells in the progression of esophageal squamous cell carcinoma.
    Hu F; Tao Z; Wang M; Li G; Zhang Y; Zhong H; Xiao H; Xie X; Ju M
    Tumour Biol; 2013 Dec; 34(6):3893-9. PubMed ID: 23893384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and role of anion exchanger 1 in esophageal squamous cell carcinoma.
    Shiozaki A; Kudou M; Ichikawa D; Shimizu H; Arita T; Kosuga T; Konishi H; Komatsu S; Fujiwara H; Okamoto K; Kishimoto M; Marunaka Y; Otsuji E
    Oncotarget; 2017 Mar; 8(11):17921-17935. PubMed ID: 28160546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ephrin-independent regulation of cell substrate adhesion by the EphB4 receptor.
    Noren NK; Yang NY; Silldorff M; Mutyala R; Pasquale EB
    Biochem J; 2009 Aug; 422(3):433-42. PubMed ID: 19552627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DCLK1 inhibition attenuates tumorigenesis and improves chemosensitivity in esophageal squamous cell carcinoma by inhibiting β-catenin/c-Myc signaling.
    Zhang L; Zhou S; Guo E; Chen X; Yang J; Li X
    Pflugers Arch; 2020 Aug; 472(8):1041-1049. PubMed ID: 32533239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
    Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
    Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR‑378a‑3p exerts tumor suppressive function on the tumorigenesis of esophageal squamous cell carcinoma by targeting Rab10.
    Ding N; Sun X; Wang T; Huang L; Wen J; Zhou Y
    Int J Mol Med; 2018 Jul; 42(1):381-391. PubMed ID: 29693138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of MLL3 in esophageal squamous cell carcinoma is required for the growth and metastasis of cancer cells.
    Xia M; Xu L; Leng Y; Gao F; Xia H; Zhang D; Ding X
    Tumour Biol; 2015 Feb; 36(2):605-13. PubMed ID: 25273170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-127 is a tumor suppressor in human esophageal squamous cell carcinoma through the regulation of oncogene FMNL3.
    Gao X; Wang X; Cai K; Wang W; Ju Q; Yang X; Wang H; Wu H
    Eur J Pharmacol; 2016 Nov; 791():603-610. PubMed ID: 27645894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
    BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
    Nguyen TM; Arthur A; Hayball JD; Gronthos S
    Stem Cells Dev; 2013 Oct; 22(20):2751-64. PubMed ID: 23711177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.
    Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL
    Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
    Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand.
    Rutkowski R; Mertens-Walker I; Lisle JE; Herington AC; Stephenson SA
    Int J Cancer; 2012 Sep; 131(5):E614-24. PubMed ID: 22161689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.